Plasma BDNF levels following weight recovery in anorexia nervosa

Abstract Objective Preclinical studies have implicated brain-derived neurotrophic factor (BDNF) in the regulation of eating behavior and body weight. As reviewed in this report, prior studies of BDNF levels in anorexia nervosa have yielded variable results, perhaps reflecting effects of malnutrition and psychiatric comorbidity. The goal of the current report was to assess plasma BDNF as a biomarker in weight-recovered individuals with a history of anorexia nervosa (AN WR ). Methods Study groups included women meeting criteria for AN WR and healthy female controls. Participants were in a normal weight range, free of current major psychiatric disorder, and free of medication. Self-ratings included eating disorder symptoms, depression and anxiety. Plasma BDNF levels were measured by enzyme linked immunoassay. Results Plasma BDNF levels were not significantly different for AN WR and control groups. Plasma BDNF levels were inversely correlated with anxiety ratings in controls ( p WR group. Discussion This report provides new evidence that circulating BDNF concentrations do not differ in healthy controls and AN WR free of psychiatric comorbidity. Additionally, the data provide new information on the relationship between plasma BDNF and anxiety in these two study groups.